The ISPAD 2018 Achievement Award has been awarded to Prof. Moshe Phillip.

Prof. Moshe Phillip will be delivering a lecture entitled “The emerging digital world of diabetes” during the President’s Welcome and Opening Lecture on October 11, 2018, from 08:00-09:00.

 

Prof. Moshe Phillip graduated from Ben Gurion University, Beer Sheba, Israel, in 1983 and specialized in pediatric endocrinology in 1989-1992 at the University of Maryland School of Medicine, in Baltimore, Maryland.  Prof. Phillip is the Director of the Institute for Endocrinology and Diabetes, the National Center for Childhood Diabetes at the Schneider Children’s Medical Center, Petah Tikva, Israel since 1997, and serves as Vice Dean for Research and Development as well as a Chair of the Irene and Nicholas Marsh Fund for Endocrinology and Diabetes at the Sackler Faculty of Medicine, Tel Aviv University. Previously (1992-1997), Prof. Phillip was the Division Head of the Pediatric and Therapeutic Center at Soroka Medical Center in Beer Sheba

Prof. Phillip is active in both clinical and basic research focusing on childhood diabetes, growth, nutrition, and obesity.

In the past few years Prof. Phillip has been focusing his research on: (1) Diabetes technologies (2) The interaction between nutrition and growth.

Prof. Phillip is a member of national and international organizations, such as the, the Israeli National Committee for Diabetes, International Society of Pediatric and Adolescent Diabetes (ISPAD), The European Society for Pediatric Endocrinology (ESPE), The Pediatric Endocrine Society (PES), Endocrine Society and more. He is the coordinator of the ESPE’s annual Diabetes, Obesity and Metabolism School and the ESPE’s Working Group on Diabetes Technologies. Prof. Phillip is the Co-Founder and Co-Chairman of the International Conference for Advanced Technologies and Treatments for Diabetes (ATTD) and of the International Conference on Nutrition and Growth (N&G).

Prof. Phillip established DreaMed-Diabetes Ltd. for moving into the phase of commercialization of the Artificial Pancreas first developed at Schneider Hospital.

Two other companies were established: Nutriteen Ltd and NG Solutions Ltd. for the commercialization of a special formula – a protein powder, blended into a shake, that boosts children’s nutrition and helps them grow.

Prof. Phillip has published more than 250 manuscripts, the ATTD Yearbook, N&G yearbook, as well as chapters in other books.